This study demonstrates that combined pharmacological abrogation of the sEH and EP4 pathways inhibits chemotherapy-induced cancer progression by preventing the protumorigenic cytokine storm via clearance of tumor cell debris (Fig. 6). This evidence concerns the gene EPHX2 and cancer.